Afyx Therapeutics A/S: Financial statements 2025
CVR: 38793594
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Afyx Therapeutics A/S (CVR 38793594) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 23,138,320 and a net result of DKK 1,518,132 compared with DKK -3,810,585 the year before. That is a decrease of 1.4% compared with the year before. Equity in the 2025 report amounted to DKK 36,178,254. The solvency ratio was 88.5%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 23,138,320
- Profit/Loss
- DKK 1,518,132
- Equity
- DKK 36,178,254
- Total Assets
- DKK 40,860,660
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 23.1M | 1.5M | 36.2M | 5 |
| 2024 | - | 23.5M | -3.8M | 9.7M | 11 |
| 2023 | - | 6.4M | -2.3M | 4.7M | 5 |
| 2022 | - | -3.2M | -7.3M | -1M | 3 |
| 2021 | - | 1.5M | -814K | 6.2M | 2 |
Official annual report
How creditworthy is Afyx Therapeutics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Afyx Therapeutics A/S has published its annual report for 2024. Gross profit came to DKK 23,467,830, and the net result was DKK -3,810,585.
About Afyx Therapeutics A/S
Afyx Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Inphena A/S and Inphena ApS. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Capital ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 23,138,320 and a net result of DKK 1,518,132 compared with DKK -3,810,585 the year before. Equity in the 2025 report amounted to DKK 36,178,254.
